DGAP-Adhoc: MeVis Medical Solutions AG: Agreement on the conclusion of a domination agreement between VMS Deutschland Holdings GmbH and MeVis Medical Solutions AG


MeVis Medical Solutions AG  / Key word(s): Miscellaneous

29.04.2015 11:34

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bremen, April 29, 2015 - The management of VMS Deutschland Holdings GmbH,
Darmstadt, and the Executive Board of MeVis Medical Solutions AG [ISIN:
DE000A0LBFE4] have agreed today to prepare and to close a domination
agreement between VMS Deutschland Holdings GmbH as controlling company and
MeVis Medical Solutions AG as controlled company. The cash compensation and
guaranteed dividend for minority shareholders of MeVis Medical Solutions AG
will be determined in accordance with the statutory requirements and on the
basis of a pending evaluation of the company. In order to become effective,
the intended domination agreement requires the approval of the general
shareholders' meeting of MeVis Medical Solutions AG, which will be
scheduled in the second half of the year.

VMS Deutschland Holdings GmbH, an affiliate of Varian Medical Systems,
Inc., Palo Alto, California, USA, published a voluntary public takeover
offer on January 27, 2015 to all shareholders of MeVis Medical Solutions AG
to acquire their registered non-par value shares against payment of 17.50
Euros per share. The offer was accepted for 1,337,995 shares (representing
73.52 % of the total share capital). The settlement of the offer was
completed on April 21, 2015, so that VMS Deutschland Holdings GmbH acquired
on this date the majority of shares in MeVis Medical Solutions AG.


29.04.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      MeVis Medical Solutions AG
              Caroline-Herschel-Str. 1
              28359 Bremen
              Germany
Phone:        +49 421 224 95 0
Fax:          +49 421 224 95 999
E-mail:       ir@mevis.de
Internet:     http://www.mevis.de
ISIN:         DE000A0LBFE4
WKN:          A0LBFE
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated
              Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------